METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA
Canada
2132208
Filed on 1993-03-29
2132208
Filed on 1993-03-29
METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA
Australia
39694/93
Filed on 1993-03-29
39694/93
Filed on 1993-03-29
Peptides Stimulating Cytotoxic Lymphocytes Response to HIV-1 GP 160
European Patent
93907180.9
Filed on 1993-03-06
93907180.9
Filed on 1993-03-06
POTENT PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR THE HIV-1 ENVELOPE
Canada
2131153
Filed on 1993-03-08
2131153
Filed on 1993-03-08
POTENT PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR THE HIV-1 ENVELOPE
Australia
37878/93
Filed on 1993-03-08
37878/93
Filed on 1993-03-08
SPECIFIC TOLERANCE IN TRANSPLANTATION
Japan
05-509445
Filed on 1992-11-19
05-509445
Filed on 1992-11-19
SPECIFIC TOLERANCE IN TRANSPLANTATION
Australia
31371/93
Filed on 1992-11-19
31371/93
Filed on 1992-11-19
BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS
Italy
92923053.0
Filed on 1992-10-30
92923053.0
Filed on 1992-10-30
BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS
Germany
92923053.0
Filed on 1992-10-30
92923053.0
Filed on 1992-10-30
BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS
France
92923053.0
Filed on 1992-10-30
92923053.0
Filed on 1992-10-30